These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 6797058
21. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Twining SS, Kirschner SE, Mahnke LA, Frank DW. Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2699-712. PubMed ID: 8344792 [Abstract] [Full Text] [Related]
22. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase. Sanai Y, Morihara K, Tsuzuki H, Homma JY, Kato I. FEBS Lett; 1980 Oct 20; 120(1):131-4. PubMed ID: 6254804 [No Abstract] [Full Text] [Related]
23. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Azghani AO. Am J Respir Cell Mol Biol; 1996 Jul 20; 15(1):132-40. PubMed ID: 8679217 [Abstract] [Full Text] [Related]
24. Interaction of pseudomonas exoproducts with phagocytic cells. Weber B, Nickol MM, Jagger KS, Saelinger CB. Can J Microbiol; 1982 Jun 20; 28(6):679-85. PubMed ID: 6811122 [Abstract] [Full Text] [Related]
26. Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Snell K, Holder IA, Leppla SA, Saelinger CB. Infect Immun; 1978 Mar 20; 19(3):839-45. PubMed ID: 417031 [Abstract] [Full Text] [Related]
27. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. Jaffar-Bandjee MC, Lazdunski A, Bally M, Carrère J, Chazalette JP, Galabert C. J Clin Microbiol; 1995 Apr 20; 33(4):924-9. PubMed ID: 7790462 [Abstract] [Full Text] [Related]
34. The role of exotoxin A in pseudomonas disease and immunity. Pollack M. Rev Infect Dis; 1983 Sep 20; 5 Suppl 5():S979-84. PubMed ID: 6419320 [Abstract] [Full Text] [Related]
35. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG. Microbiology (Reading); 2000 Aug 20; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893 [Abstract] [Full Text] [Related]
36. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Nicas TI, Iglewski BH. Can J Microbiol; 1985 Apr 20; 31(4):387-92. PubMed ID: 2988728 [Abstract] [Full Text] [Related]
37. Pseudomonas. Clinical problems related to virulence factors and development of resistance. Nordbring F. Arch Intern Med; 1982 Oct 25; 142(11):2010-1. PubMed ID: 6812525 [Abstract] [Full Text] [Related]
38. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Cash HA, Straus DC, Bass JA. Can J Microbiol; 1983 Apr 25; 29(4):448-56. PubMed ID: 6406026 [Abstract] [Full Text] [Related]
39. Reliable enzyme-linked immunosorbent assay systems for pathogenic factors of Pseudomonas aeruginosa alkaline proteinase, elastase, and exotoxin A: a comparison of methods for labeling detection antibodies with horseradish peroxidase. Shigematsu T, Suda N, Okuda K, Fukushima J. Microbiol Immunol; 2007 Apr 25; 51(12):1149-59. PubMed ID: 18094533 [Abstract] [Full Text] [Related]
40. Effects of proteases on the structure and activity of Pseudomonas aeruginosa exotoxin A. Morihara K, Sanai Y, Tsuzuki H, Jyoyama H, Hirose K, Homma JY, Kato I. Infect Immun; 1981 Nov 25; 34(2):435-40. PubMed ID: 7030958 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]